The present study was aimed at creating a combination between lower dose of sulfamethoxazole (S) as a broad-spectrum synthetic antibiotic and quercetin (Q), a natural polyphenol to decrease the antibiotic side effects and increase its antioxidant activity. Staphylococcus aureus infected animal model was studied both in vitro and in vivo in comparison to doxycycline (Dox) as standard antibiotic. The in vitro test results indicated that Q exhibited activity alone and in combination with S against tested bacterial strains, while S in low concentration was inactive. The in vivo results revealed that the S+Q combination in mice showed significant improvements in the liver and kidney functions as compared to those in the infected group or S- and Dox-treated groups. Moreover, malondialdehyde level was significantly decreased, while superoxide dismutase and catalase activities were significantly increased in the sera of (S+Q)-treated group in comparison to other treated groups. The spleen recovery in the (S+Q)-treated group was observed with the disappearance of S. aureus colonies as compared to the infected mice. In conclusion, the in vivo treatment of S. aureus infection with S+Q combination decreased the sulfamethoxazole side effects while increasing its antibacterial activity, which supported the therapeutic use of this combination in humans.
Similar content being viewed by others
References
J.-P. Gaudillière, Bull. Hist Med, 83(1), 218 – 220 (2009).
S. Jones, Nat. Biotechnol., 30(6), 333 – 333 (2012).
L. L. Brunton, J. S. Lazo, K. Parker, et al., Ann. Pharmacother., 40(6), 1218 (2006).
S. R. M. Bushby and G. H. Hitchings, Br. J. Pharm. Chemother., 33(1), 72 – 90 (1968).
M. J. ONeil, P. E. Heckelman, C. B. Koch, et al., The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals, Merck & Co., Whitehouse Station, NJ, USA. (2006), pp. 1525 – 1535.
M. A. Kielhofner, Tex. Heart. Inst. J., 17(2), 86 – 93 (1990).
T. P. T. Cushnie and A. J. Lamb, Int. J. Antimicrob. Agents, 26(5), 343 – 356 (2005).
H. Liu, Y. Mou, J. Zhao, et al, Molecules, 15(11), 7933 – 7945 (2010).
L. Zhou, D. Li, J. Wang, et al, Nat. Prod. Res., 21(4), 283 – 291 (2007).
V. Chobot, J. Agric. Food Chem., 58(4), 2088 – 2094 (2010).
L. Sampson, E. Rimm, P. C. H. Hollman, et al., J. Am. Diet. Assoc., 102(10), 1414 – 1420 (2002).
R. J. Anderson, P. W. Groundwater, A. Todd, et al., Antibacterial Agents: Chemistry, Mode of Action, Mechanisms of Resistance and Clinical Applications, John Wiley & Sons (2012), pp. 127 – 140.
M. Lesjak, I. Beara, N.Simin, et al., J. Funct. Foods, No. 40, 68 – 75 (2018).
S. C. Cheng, Y. H. Wu, W. C. Huang, et al., Cytokine, No. 116, 48 – 60 (2019).
K. Takashima, M. Matsushima, K. Hashimoto, et al., Respir. Res., 15(1),150 (2014).
M. Amin, K. S. Putra, I. F. Amin, et al., Biol. Med. Nat. Prod. Chem., 7(1), 27 – 31 (2018).
Y. Su, L. Ma, Y. Wen, et al., Molecules, 19(8), 12630 – 12639 (2014).
K. A. Ohemeng, C. F. Schwender, K. P. Fu, et al., Bioorg. Med. Chem. Lett., 3(2), 225 – 230 (1993).
Z. C. Xing, W. Meng, J. Yuan, et al., J. Nanomater., No. 2012, 1 – 7 (2012).
O. K. Mirzoeva, R. N. Grishanin and P. C. Calder, Microbiol. Res., 152(3), 239 – 246 (1997).
I. Hirai, M. Okuno, R. Katsuma, et al., Int. J. Food. Sci. Technol., 45(6), 1250 – 1254 (2010).
M. K. Sakharkar, P. Jayaraman, W. Mar Soe, et al., J. Microbiol. Immunol. Infect., 42(5), 364 – 370 (2009).
B. M. Kyaw, S. Arora and C. S. Lim, Braz. J. Microbiol., 43(3), 938 – 945 (2012).
M. Amin, M. Khurram, B. Khattak, et al., BMC Complement. Altern. Med., No. 15, 59 (2015).
M. U. Amin, M. Khurram, T. A. Khan, et al., Int. J. Mol. Sci., 17(11), 1947 (2016).
G. M. Garrity, D. J. Brenner, N. R. Krieg, et al., Bergeys Manual Of Systematic Bacteriology, Springer, New York (2005), Vol. 2, Part B.
A. L. Barry, W. A. Craig, H. Nadler, et al., Methods for Determining Bactericidal Activity of Antimicrobial Agents, Approved Guideline, Clinical and Laboratory Standards Institute, NCCLS (1999), Vol. 19, No. 18.
S. C. Becerra, D. C. Roy, C. J. Sanchez, et al., BMC Res. Notes, No. 19, 1 – 10 (2016).
P. G. Engelkirk and J. L. Duben-Engelkirk, Laboratory Diagnosis of Infectious Diseases, Baltimore, Wolters Kluwer Health, Lippincott Williams & Wilkins, (2008) pp. 124 – 140.
A. Bauer, W. Kirby, J. Sherris, et al., Am. J. Clin. Pathol., 1(6), 451 – 459 (1972).
Methods for Dilution Antimicrobial Susceptibility Tests forBacteria That Grow Aerobically, Approv. Stand. Ed. CLSI Doc., M07-A10, Clinical and Laboratory Standards Institute (2015), Vol. 35, pp 1 – 87.
L. Yao, J. W. Berman, S. M. Factor, et al., Infect. Immun., 65(9), 3889 – 3895, (1997).
M. Tsuji, Y. Ishii, A. Ohno, et al., Antimicrob. Agents Chemother., 42(1) 94 – 99, (1998).
O. A. Igbeneghu, E. O. Iwalewa and A. Lamikanra, Phyther. Res., 21, 67 – 71 (2007).
H. K, Kim, D. Missiakas and O. Schneewind, Immunol. Methods, No. 410, 88 – 99 (2014).
R. Gupta, I. Kazmi, M. Afzal, et al., Mol. Cell Biochem., 384, 279 – 285 (2013).
M. A. Indap, S. C. Bhosle, A. D. Shinde, et al., Indian J. Pharm. Sci., No. 1, 570 – 574 (2006).
M. Fujita, Q. Ye, H. Ouchi, et al., Antimicrob. Agents Chemother., No. 50, 739 – 743 (2006).
C. Bell, in: Clinical Guide to Laboratory Tests, Ed. by Norbert W. Tietz (1995); Transfusion, Vol. 35, Issue 11, pp. 972 – 972.
E. R. Jaff, New Engl. J. Med., 286(3), 156–157 (1972).
D. E. Stanley, J. Am. Med. Assoc., 282(3). 283 (1999).
J. H. Wilkinson, D. N. Baron, D. W. Moss, et al., J. Clin. Pathol., 25(11), 940 – 944 (1972).
B. T. Doumas, W. A. Watson and H. G. Biggs, Clin. Chim. Acta, 258(1), 21 – 30 (1997).
M. Nishikimi, N. Appaji Rao, K. Yagi, Biochem. Biophys. Res. Commun., 46(2), 849 – 854 (1972).
H. Aebi, Methods Enzymol., No. 105, 121 – 126 (1984).
Z. A. Placer, L. L. Cushman and B. C. Johnson, Anal. Biochem., 16(2), 359 – 364 (1966).
G. P. Wormser, G. T. Keusch and R. C. Heel, Drugs, 24(6), 459 – 518 (1982).
S. Hemaiswarya, A. K. Kruthiventi, and M. Doble, Phytomedicine, 15(8), 639 – 652 (2008).
A. M. L. Hossion, N. Otsuka, R. K. Kandahary, et al., Bioorg. Med. Chem. Lett., 20(17), 5349 – 5352 (2010).
Y. Xie, W. Yang, F. Tang, et al., Curr. Med. Chem., 22(1), 132 – 149 (2014).
I. Hirai, M. Okuno, R. Katsuma, et al., Int. J. Food. Sci. Technol., 45(6), 1250 – 1254 (2010).
H. Jaeschke, C. D. Williams, M. R. McGill, et al., Food. Chem. Toxicol., No. 55, 279 – 289 (2013).
G. Ibrahim Qader, R. Aziz, Z. Ahmed, et al., Am. J. Pharmacol. Sci., 2(3), 56 – 60 (2014).
I. M. S. Santos, A. da R. Tome G. B. Saldanha, et al., Oxid. Med. Cell Longev., 2(4), 214 – 221 (2009).
M. Bagchi, D. Bagchi, E, Adickes, et al., J. Environ. Pathol. Toxicol. Oncol. Off. Organ. Int. Soc. Environ. Toxicol. Cancer., 14(2), 61 – 68 (1995).
L. Ashakumary and P. L. Vijayammal, J. Appl. Toxicol., 16(4), 305 – 308 (1996).
C. G. M. Heijnen, G. R. M. M. Haenen, F. A. A. Van Acker, et al., Toxicol Vitr., 15(1), 3 – 6 (2001).
P. C. Hollman, J. M. van Trijp, M. N. C. Buysman, et al., FEBS Lett., 418(1 – 2), 152 – 156 (1997).
Acknowledgments
The authors appreciate the assistance of Dr. Baher El-Nogoumy, microbiology lecturer (Microbiology Department, Faculty of Science, Kafrelsheikh University, Kafrelsheikh, Egypt) for his help in identification of clinical isolates in this study.
Funding
The authors declare that there has been no funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Mice were handled according to the experimental practice and standards approved by the institutional ethical committee (IEC) of Kafrelsheikh University, Egypt. The authors represented a new University and did not get an approval number yet. There were no experiments on human subjects.
Conflict of Interest
The authors declare that they have no conflicts of interest.
Rights and permissions
About this article
Cite this article
Sahyon, H.A., Ramadan, E.N.M. & Mashaly, M.M.A. Synergistic Effect of Quercetin in Combination with Sulfamethoxazole as New Antibacterial Agent: In Vitro and In Vivo Study. Pharm Chem J 53, 803–813 (2019). https://doi.org/10.1007/s11094-019-02083-z
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-019-02083-z